Journey Medical (DERM) Retained Earnings (2020 - 2026)

Journey Medical has reported Retained Earnings for 7 years, with the latest figure at -$100.7 million in Q1 2026.

• For the quarter ending Q1 2026, Retained Earnings fell 10.52% year-over-year to -$100.7 million; the trailing twelve-month figure through Mar 2026 stood at -$100.7 million (down 10.52% YoY), and the FY2025 full-year result was -$98.5 million, down 13.14% from the prior year.
• Retained Earnings for Q1 2026 stood at -$100.7 million, down from -$98.5 million in the prior quarter.
• The five-year high for Retained Earnings was -$40.3 million in Q1 2022, with the low at -$100.7 million in Q1 2026.
• Historically, Retained Earnings has averaged -$79.4 million across 5 years, with a median of -$86.2 million in 2024.
• Annual changes were most pronounced in 2022 — Retained Earnings plunged 237.91% — and 2024, when it advanced 0.97%.
• Journey Medical's Retained Earnings stood at -$68.5 million in 2022, then dropped by 5.62% to -$72.4 million in 2023, then decreased by 20.28% to -$87.0 million in 2024, then retreated by 13.14% to -$98.5 million in 2025, then decreased by 2.26% to -$100.7 million in 2026.
• The last three Retained Earnings figures came in at -$100.7 million (Q1 2026), -$98.5 million (Q4 2025), and -$97.2 million (Q3 2025), per Business Quant data.